Profile data is unavailable for this security.
About the company
Acotec Scientific Holdings Ltd is a company engaged in interventional medical device business. The Company is primarily engaged in the research and development on providing treatment solutions for vascular diseases, involving drug-coated balloons (DCB) and percutaneous transluminal angioplasty balloon catheters (PTA). The Company’s main products include AcoArt Orchid & Dhalia, AcoArt Tulip & Litos, AcoArt Iris & Jasmin, AcoArt Lily & Rosmarin, Peripheral Aspiration System (AcoStream), Radiofrequency Ablation System (AcoArt Cedar), 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream) and others, covering fields such as vascular surgery, cardiology, nephrology and neurology. The Company conducts businesses within domestic and overseas markets.
- Revenue in HKD (TTM)673.73m
- Net income in HKD114.66m
- Incorporated2020
- Employees645.00
- LocationAcotec Scientific Holdings Ltd4F to 5F, Building 1No. 16, Hongda North Road, Beijing Econoand Technological Development ZoneBEIJING 100176ChinaCHN
- Websitehttps://www.acotec.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ethk Labs Inc | 3.48bn | 197.10m | 1.78bn | 877.00 | 9.21 | 0.459 | 7.33 | 0.5114 | 0.1205 | 0.1205 | 2.13 | 2.42 | 0.536 | 1.06 | 6.84 | 4,034,953.00 | 3.08 | 4.60 | 4.86 | 6.04 | 22.94 | 21.71 | 5.74 | 7.17 | 0.5095 | 5.12 | 0.3196 | -- | 2.40 | 6.27 | 9.35 | -1.08 | 10.78 | -- |
| PW Medtech Group Ltd | 955.63m | 165.78m | 1.90bn | 1.36k | 11.72 | 0.4371 | 5.23 | 1.99 | 0.1101 | 0.1101 | 0.6353 | 2.95 | 0.1603 | 2.91 | 11.47 | 675,355.30 | 3.52 | 7.71 | 4.42 | 8.74 | 52.62 | 56.56 | 21.96 | 75.91 | 9.12 | -- | 0.0042 | 8.38 | 13.90 | 16.25 | -1.57 | 12.96 | 8.75 | -- |
| OrbusNeich Medical Group Holdings Ltd | 1.32bn | 317.43m | 3.03bn | 1.43k | 9.51 | 0.9497 | 8.37 | 2.30 | 0.3848 | 0.3848 | 1.60 | 3.85 | 0.3919 | 0.9325 | 4.20 | 989,374.40 | 9.48 | 7.59 | 10.29 | 9.02 | 67.91 | 68.61 | 24.19 | 16.07 | 9.95 | -- | 0.0107 | 10.02 | 6.65 | 11.24 | -11.88 | 41.68 | 29.71 | -- |
| MicroTech Medical (Hangzhou) Co Ltd | 498.52m | -31.30m | 3.07bn | 645.00 | -- | 1.39 | -- | 6.16 | -0.0751 | -0.0751 | 1.19 | 5.29 | 0.2015 | 3.65 | 4.02 | 735,275.10 | -1.27 | -4.48 | -1.38 | -4.70 | 48.65 | 48.32 | -6.28 | -39.29 | 8.33 | -- | 0.0154 | -- | 36.48 | 46.13 | 49.51 | -- | 22.22 | -- |
| Jenscare Scientific Co Ltd | 15.19m | -276.91m | 3.27bn | 174.00 | -- | 3.32 | -- | 215.09 | -0.6792 | -0.6792 | 0.0373 | 2.36 | 0.0125 | 0.0508 | -- | 71,972.84 | -23.35 | -- | -24.76 | -- | 88.09 | -- | -1,864.69 | -- | 6.39 | -854.86 | 0.0631 | -- | -- | -- | 52.25 | -- | -- | -- |
| Acotec Scientific Holdings Ltd | 670.58m | 114.13m | 3.48bn | 645.00 | 29.65 | 2.13 | 20.02 | 5.19 | 0.3743 | 0.3743 | 2.23 | 5.21 | 0.3353 | 1.06 | 3.53 | 1,031,664.00 | 5.71 | 0.2467 | 6.45 | 0.289 | 75.23 | 81.33 | 17.02 | 0.7122 | 5.57 | -- | 0.1406 | 0.00 | 12.69 | 33.72 | 260.88 | 17.74 | 83.44 | -- |
| Guanze Medical Infrm Indstry (Hldng) Ltd | 166.91m | 23.45m | 3.60bn | 58.00 | 154.13 | 12.09 | 109.87 | 21.57 | 0.0246 | 0.0246 | 0.1763 | 0.3135 | 0.5073 | 2.21 | 1.30 | 2,928,283.00 | 7.23 | 9.50 | 8.33 | 12.04 | 36.79 | 41.43 | 14.25 | 13.09 | 5.23 | 51.53 | 0.0544 | 34.79 | -0.2127 | 2.03 | -37.59 | -5.08 | 24.24 | -- |
| Peijia Medical Ltd | 755.20m | -254.71m | 3.83bn | 1.04k | -- | 1.71 | -- | 5.07 | -0.385 | -0.385 | 1.14 | 3.33 | 0.2561 | 1.40 | 17.04 | 721,295.40 | -8.76 | -26.57 | -10.02 | -28.99 | 69.25 | 71.23 | -34.21 | -247.65 | 1.49 | -15.30 | 0.1396 | -- | 39.53 | 101.13 | 42.28 | -- | 83.33 | -- |
| MicroPort CardioFlow Medtech Corp | 415.72m | 5.49m | 4.11bn | 417.00 | 274.31 | 0.6313 | 38.25 | 9.89 | 0.0118 | 0.0118 | 0.8923 | 5.12 | 0.1423 | 1.00 | 1.77 | 966,782.60 | 0.0886 | -13.38 | 0.0996 | -16.84 | 69.08 | 64.41 | 0.6228 | -124.49 | 6.50 | -- | 0.112 | -- | 7.54 | 75.85 | 89.51 | -- | 26.60 | -- |
Data as of Mar 05 2026. Currency figures normalised to Acotec Scientific Holdings Ltd's reporting currency: Hong Kong Dollar HKD
0.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 30 Jun 2025 | 406.00k | 0.13% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 37.00k | 0.01% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 5.04k | 0.00% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
